Condition: Breast Cancer · Sponsor: Weill Medical College of Cornell University
This study is comparing two different radiation therapy approaches for early breast cancer to see which one is better for patients. One group will receive radiation over one week (based on the FAST-FORWARD trial), and the other group will receive radiation over two weeks with an extra focused dose (called a "concomitant boost"). The study will look at how the treatments affect side effects, breast appearance, and cancer control in the breast. It also aims to find out if the two-week treatment does a better job at preventing cancer from coming back in the breast over the long term.
This description comes directly from the study's public registry record.
Fabiana Gregucci, MD · 6469623110 · fgr4002@med.cornell.edu
Fereshteh Talebi, MD · 6467027830 · fet4007@med.cornell.edu
Always discuss trial participation with your own doctor first.
| Brooklyn Methodist Hospital | New York, New York, United States | Recruiting |
| New York Presbyterian Hospital | New York, New York, United States | Recruiting |
| New York-Presbyterian Weill Cornell Medical College | New York, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06960707